Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 15
2005 10
2006 7
2007 3
2008 2
2009 3
2010 3
2011 4
2012 3
2013 6
2014 3
2015 3
2016 1
2017 2
2018 1
2020 3
2021 3
2022 5
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.
Falsey AR, Sobieszczyk ME, Hirsch I, Sproule S, Robb ML, Corey L, Neuzil KM, Hahn W, Hunt J, Mulligan MJ, McEvoy C, DeJesus E, Hassman M, Little SJ, Pahud BA, Durbin A, Pickrell P, Daar ES, Bush L, Solis J, Carr QO, Oyedele T, Buchbinder S, Cowden J, Vargas SL, Guerreros Benavides A, Call R, Keefer MC, Kirkpatrick BD, Pullman J, Tong T, Brewinski Isaacs M, Benkeser D, Janes HE, Nason MC, Green JA, Kelly EJ, Maaske J, Mueller N, Shoemaker K, Takas T, Marshall RP, Pangalos MN, Villafana T, Gonzalez-Lopez A; AstraZeneca AZD1222 Clinical Study Group. Falsey AR, et al. Among authors: mueller n. N Engl J Med. 2021 Dec 16;385(25):2348-2360. doi: 10.1056/NEJMoa2105290. Epub 2021 Sep 29. N Engl J Med. 2021. PMID: 34587382 Free PMC article. Clinical Trial.
First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors.
Bendell J, LoRusso P, Overman M, Noonan AM, Kim DW, Strickler JH, Kim SW, Clarke S, George TJ, Grimison PS, Barve M, Amin M, Desai J, Wise-Draper T, Eck S, Jiang Y, Khan AA, Wu Y, Martin P, Cooper ZA, Elgeioushi N, Mueller N, Kumar R, Patel SP. Bendell J, et al. Among authors: mueller n. Cancer Immunol Immunother. 2023 Jul;72(7):2443-2458. doi: 10.1007/s00262-023-03430-6. Epub 2023 Apr 5. Cancer Immunol Immunother. 2023. PMID: 37016126 Free PMC article. Clinical Trial.
Public health program capacity for sustainability: a new framework.
Schell SF, Luke DA, Schooley MW, Elliott MB, Herbers SH, Mueller NB, Bunger AC. Schell SF, et al. Among authors: mueller nb. Implement Sci. 2013 Feb 1;8:15. doi: 10.1186/1748-5908-8-15. Implement Sci. 2013. PMID: 23375082 Free PMC article. Review.
Delayed SARS-COV-2 leukoencephalopathy without Severe Hypoxia.
Kumar A, Olivera A, Mueller N, Howard J, Lewis A. Kumar A, et al. Among authors: mueller n. J Neurol Sci. 2020 Nov 15;418:117146. doi: 10.1016/j.jns.2020.117146. Epub 2020 Sep 18. J Neurol Sci. 2020. PMID: 32977227 Free PMC article.
Role of the ventral subiculum in stress integration.
Herman JP, Mueller NK. Herman JP, et al. Among authors: mueller nk. Behav Brain Res. 2006 Nov 11;174(2):215-24. doi: 10.1016/j.bbr.2006.05.035. Epub 2006 Jul 28. Behav Brain Res. 2006. PMID: 16876265 Review.
Building a National Framework to Pair Scientists and Schools During a Global Pandemic.
Zimmerman KO, Goldman JL, Schuster JE, Mena A, Quiriconi M, Butteris SM, Koval S, DeMuri GP, Mueller NB, Benjamin DK, Armstrong SC, Kalu IC, Boutzoukas A, Moorthy GS, Lane H, Weber DJ, Newland JG. Zimmerman KO, et al. Among authors: mueller nb. Pediatrics. 2022 Feb 1;149(Suppl 2):e2021054268D. doi: 10.1542/peds.2021-054268D. Pediatrics. 2022. PMID: 34737179 Free PMC article.
81 results